TC | 
Stat | 
Stk | 
Ins | 
Fil | 
+d | 
+w | 
+m | 
+q | 
+h | 
+y | 
avg | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 2 | 1 | 5 | 0 | -1 | -13 | -39 | -60 | -80 | -38 | 
| S | %wins | 60 | 60 | 100 | 75 | 100 | 100 | 83 | 
Filing Date | 
					T Date | 
					Ticker | 
					Issuer | Inc | 					Sector | 
					Ind | Industry |  
						Owner | 
						oSt | 
						Rel | 
						Title | 
					 
					T | 
					TVal | 
					Price | 
					L | 
					Qty | 
					oc | 
					Own | 
					H | 
					r2y | 
					r1y | 
					r6m | 
					r3m | 
					r6w | 
					r3w | 
					r7d | 
					r3d | 
					f1d | 
					f1w | 
					f1m | 
					f3m | 
					f6m | 
					f1y | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/23/17 16:59  | 10/19/17  | VSAR | Versartis, Inc. | Health | Drug | Pharmaceutical Preparations | Hislop Colin | CA | O | Chief Me | S | -2 | 2.55 | 0 | -1 | -3 | 24 | D | |||||||||||||||
4/5/17 19:02  | 4/4/17  | VSAR | Versartis, Inc. | Health | Drug | Pharmaceutical Preparations | Hislop Colin | CA | O | Chief Me | S.d | -742 | 21.20 | 9 | -35 | -59 | 25 | D | 22 | 154 | 75 | 43 | 9 | 12 | 1 | -3 | -1 | -1 | -18 | ||||
11/18/15 18:53  | 11/13/15  | ANTH | Anthera Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Hislop Colin | CA | O | Chief Me | S.d | -66 | 5.31 | 3 | -13 | -37 | 21 | D | 59 | 183 | 6 | -41 | -18 | -18 | -15 | 0 | -4 | -7 | -9 | -49 | -42 | -71 | 
11/12/15 16:21  | 11/11/15  | ANTH | Anthera Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Hislop Colin | CA | O | Chief Me | S | -27 | 5.38 | 4 | -5 | -19 | 21 | D | 63 | 174 | 0 | -49 | -14 | -14 | -18 | -17 | 3 | 8 | -12 | -46 | -38 | -65 | 
2/6/12 20:04  | 2/3/12  | ANTH | Anthera Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Hislop Colin | CA | O | Chief Me | S | -246 | 8.20 | 0 | -30 | -35 | 55 | D | 89 | 30 | 26 | 28 | 18 | 11 | 5 | -5 | -5 | -25 | -78 | -87 | -91 | |
11/10/11 17:06  | 11/8/11  | ANTH | Anthera Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Hislop Colin | CA | O | Chief Me | S.d | -101 | 6.74 | 0 | -15 | -17 | 73 | D | 17 | -9 | 20 | 33 | 8 | 3 | -4 | 7 | 2 | 0 | 17 | -72 | -91 | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |